To further explore the gene regulating mechanisms underlying the downregulation of HSP70 in drug-resistant prostate cancer cells, we performed RNA sequencing analyses using C4-2B MDVR and CWR22Rv1 cells treated with APO or VER to identify gene programs that are affected by HSP70 inhibition. This evidence concerns the gene HSPA1A and prostate carcinoma.